This protocol applies to patients with mild linear IgA dermatosis — a presentation in which the extent of disease allows management with localised treatment, without the need to escalate to systemic therapy.
In mild linear IgA dermatosis, a potent topical agent applied to affected skin is the cornerstone of management. Systemic treatment is not required at this stage. The full protocol specifies agent selection and all further guidance.
DOI: 10.1111/jdv.19880Digital
In mild forms of mild LAD, topical corticosteroids can be used alone without the need for systemic treatments.
Potent topical corticosteroids such as clobetasol propionate are generally preferred.
View source ↗